SecBot SecBot
COURT-RULING ·Filed Jul 6, 2026

AZN

ASTRAZENECA PLC
BEARISH
Impact 5/10
Horizonmonths Processed4mo ago CourtCourt Ruling · govinfo.gov
Court ruling (appellate)
Actionable Insight ▼ Bearish

The Fifth Circuit's affirmation of Act 358 is a loss for AZN, but the financial impact is likely modest and already anticipated given similar state laws. Monitor for further state legislation and any potential Supreme Court petition. The ruling does not materially change AZN's near-term outlook given its diversified portfolio and $589B market cap.

DirectionBearish
Confidencehigh
Horizonmonths

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$193.12
T+0 close · Jul 7, 2026 · via day close
Latest settled
−16.39%
T+60 · $161.47
Vs SPY
−18.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 7 $193.12entry
  2. T+1 · 4mo ago −1.99%α −1.68% · $189.28
  3. T+5 · 4mo ago −14.82%α −15.37% · $164.50
  4. T+20 · 4mo ago −19.42%α −22.58% · $155.62
  5. T+60 · 7w ago −16.39%α −18.38% · $161.47
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The Fifth Circuit affirmed Louisiana's Act 358, which prohibits drug manufacturers from restricting 340B discounted drug delivery to contract pharmacies. AstraZeneca lost its challenge on preemption and Contracts Clause grounds. The ruling is a modest regulatory setback, potentially increasing the volume of 340B discounted sales, but the financial impact is unquantified and likely small relative to AZN's $589B market cap.

Court Ruling Details

Ruling Date
Jul 6, 2026
Court
United States Court of Appeals for the Fifth Circuit
Court Level
Appellate
Judge
Don R. Willett
Case Type
regulatory
Ruling Type
final judgment
Outcome
LOSS: ruling against this company
Precedent Risk
LOW

Key Facts

  • Fifth Circuit affirmed summary judgment for Louisiana, rejecting AstraZeneca's preemption and Contracts Clause challenges to Act 358
  • Act 358 bars manufacturers from interfering with 340B drug delivery to contract pharmacies
  • Ruling aligns with prior Fifth Circuit precedent in AbbVie v. Fitch regarding Mississippi's similar law
  • No damages awarded; no financial impact quantified in the ruling

Financial Impact

Unquantified regulatory setback, potential increase in 340B discounted drug volumes through contract pharmacies, but no immediate financial impact stated

revenue

Risk Factors

  • Further state laws restricting 340B contract pharmacy restrictions
  • Potential increased volume of 340B discounted sales reducing revenue

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-5d791a3776-AZN

Track record

77 reports on AZN

Performance horizon

18 of 37 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 28 of 37 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
  2. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.02 −0.82% settles Nov 23
  3. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.02 −0.70% settles Nov 23
  4. Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.02 −0.58% settles Nov 23
  5. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.02 −1.51% ▼ −1.32% −4.61% vs SPY
  6. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
  7. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
  8. Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.02 −1.41% ▼ −0.12% +2.59% vs SPY
  9. Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.02 +8.20% ▲ +8.11% +10.10% vs SPY
  10. Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.02 +6.63% ▲ +0.51% −0.19% vs SPY
Showing 10 of 77

US Market Status

Market Closed · Opens Wed (10h 55m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Jul 7, 2026